Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact Pricing
Login Book a demo
Zenflow, Inc. logo — company profile

Zenflow, Inc.

Founded 2014 United States South San Francisco, United States 29 employees Series B Total: $56.07M Health Care, Health and Wellness +1

General Information

Company Name Zenflow, Inc.
Founded Year 2014
Location United States South San Francisco, United States
Employees 29
Industries Health Care, Health and Wellness, Medical Devices
Funding Stage Series B
Social

BounceWatch is an independent company data service, not affiliated with Zenflow, Inc.. To contact Zenflow, Inc., visit zenflow.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

About Zenflow, Inc.

Zenflow, Inc. is a Health Care startup founded in 2014, headquartered in the United States. The company addresses the unmet clinical need of millions of men suffering from urinary obstruction related to benign prostatic hyperplasia (BPH). Their Spring System offers a non-invasive alternative to surgical procedures, providing effective relief without the high risk of side effects like sexual dysfunction from drugs. Their latest milestone includes a $24.37M Series B investment on 15 April 2021, led by F-Prime Capital, Golden Seeds, Cloudstone Capital, SV Tech Ventures, Propel(X), Astia Angels, and Invus Opportunities. Ongoing clinical trials have shown positive results up to four years after treatment. With this significant investment and promising clinical outcomes, Zenflow is poised to make a considerable impact in the healthcare industry.

Taxonomy: Benign Prostatic Hyperplasia, Urology, Medical Innovation, Clinical Trials, BPH Treatment, Minimally Invasive Procedure, Patient Relief, Stanford University, Biodesign, Fellows, Urological Devices, Chronic Condition

Funding Rounds & Investors (6)

View All
Funding Stage Amount Investors Lead Investors Date
Series B $24.37M 7
F-Prime Capital Golden Seeds Cloudstone Capital
F-Prime Capital, Golden Seeds +5
15 Apr 2021
Grant Undisclosed 2
National Science Foundation
National Science Foundation, National Institutes of Health
07 Feb 2018
Series A $31.40M 9
UpHonest Capital F-Prime Capital Invus
UpHonest Capital, F-Prime Capital +7
07 Feb 2018
Venture Round Undisclosed 1
Eight Roads Ventures
Eight Roads Ventures
01 Jan 2017
Grant $180.00K 1
National Science Foundation
National Science Foundation
26 Jun 2015
Seed Round $120.00K 3
Y Combinator SP Investment Fund
Y Combinator, SP Investment Fund +1
23 Mar 2015

Zenflow, Inc. Alternatives & Competitors

View All Alternatives
Zenflow, Inc. vs
Embolx, Inc.
Embolx, Inc. United States

Embolx is an emerging commercial-stage medical device company in Silicon Valley developing microcath...

Seed
15 employees
Health Care, Manufacturing
Zenflow, Inc. vs
Prostacare
Prostacare Australia

Beyond symptoms, towards solutions | Prostacare's Neuflo BPH Treatment System

5 employees
Health Care, Manufacturing
Zenflow, Inc. vs
Zelegent
Zelegent United States

Sleep Better. Live Better. Reduce the severity of snoring and the associated negative health effect...

Venture round
3 employees
Health Care, Medical Devices
View all alternatives

FAQ About Zenflow, Inc.

Forty million men in the US and over 500 million worldwide suffer from urinary obstruction related to benign prostatic hyperplasia (BPH). Millions of patients do not see effective relief from drugs, yet decline to undergo an invasive surgical procedure with high risk of side effects such as sexual d...
Zenflow, Inc. was founded in 2014.
Zenflow, Inc. is headquartered in South San Francisco, United States.
Zenflow, Inc. operates in Health Care, Health and Wellness and Medical Devices. Its work centres on Benign Prostatic Hyperplasia, Urology, Medical Innovation and Clinical Trials.
Zenflow, Inc. has approximately 29 employees.
Zenflow, Inc. has completed 6 funding rounds, raising a total of $56.07M. The latest funding stage is Series B.
Top alternatives and competitors to Zenflow, Inc. include Embolx, Inc., Prostacare, Zelegent, Novian Health, Northwest Urology LLC. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Zenflow, Inc. and Embolx, Inc. are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for Zenflow, Inc., https://bouncewatch.com/company/zenflow-inc, updated 30 December 2024. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Book a demo 30 minutes